TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Nordic Biomarker AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
132,367
|
122,335
|
129,627 |
| Financial expenses |
1,254
|
2,029
|
1,804 |
| Earnings before taxes |
-7,344
|
-40,723
|
-25,311 |
| EBITDA |
9,477
|
-27,102
|
-14,454 |
| Total assets |
168,773
|
163,333
|
208,098 |
| Current assets |
83,488
|
69,278
|
71,014 |
| Current liabilities |
38,367
|
80,304
|
71,158 |
| Equity capital |
124,303
|
75,459
|
135,293 |
| - share capital |
150
|
150
|
150 |
| Employees (average) |
53
|
69
|
75 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
73.7%
|
46.2%
|
65.0% |
| Turnover per employee |
2,497
|
1,773
|
1,728 |
| Profit as a percentage of turnover |
-5.5%
|
-33.3%
|
-19.5% |
| Return on assets (ROA) |
-3.6%
|
-23.7%
|
-11.3% |
| Current ratio |
217.6%
|
86.3%
|
99.8% |
| Return on equity (ROE) |
-5.9%
|
-54.0%
|
-18.7% |
| Change turnover |
10,032
|
-7,292
|
-1,114 |
| Change turnover % |
8%
|
-6% | |
| Chg. No. of employees |
-16
|
-6
|
9 |
| Chg. No. of employees % |
-23%
|
-8% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.